Description: Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells for the cosmetic sector primarily in Spain. It offers Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Photobiome a microbiota photoprotector; Olea Vitae cellular oil for ageing; Turmeria Zen for skin hydration and wrinkles on stressed profiles; Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins; Deobiome Noni, a biological deodorant; and Sarcoslim Re-Shape to reduce fat on tissue. The company also offers Capilia Longa for hair growth reactivation; Luminia Granatum for skin brightening;Elaya Renova a hair tensegrist; Kannabia Sense that stimulates the microbiota-skin-brain axis; Quora Noni to avoid the attack of skin harmful bacteria; Quora Noni biomics for rejuvenating the skin microbiota; Centella Reversa for facial complexion improvement; and Arabian Cotton for protection against photo-ageing. It sells its products to approximately 560 countries. Vytrus Biotech, S.A. was incorporated in 2009 and is based in Barcelona, Spain.
Home Page: www.vytrus.com
Sant Gaietà 121, 2nd
Barcelona,
08221
Spain
Phone:
34 93 127 81 06
Officers
| Name | Title |
|---|---|
| Mr. Albert Jane Font | Co-Founder, Co-CEO, President, Member of Management Board & Director |
| Mr. Oscar Exposito Tarres | Co-Founder, Co-CEO, C.S.O, Member of Management Board & Director |
| Mr. Jordi Rovira Martinez | CFO, Member of Management Board, Secretary of the Board & Director |
| Mr. Daniel Robustillo | Sales Director & Member of Management Board |
| Mr. Manel Lopez | COO & Member of Management Board |
| Ms. Sara Laplana | Executive CSO & Member of Management Board |
| Alejandro Guirado | Communication & Marketing Manager |
| Conxita Rusines | ESG & People Wellbeing Manager |
Exchange: MC
Country: ES : Spain
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 22 |
| Price-to-Book MRQ: | 2.4677 |
| Price-to-Sales TTM: | 3.2072 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 35 |